62.2 F
New York
Friday, September 24, 2021

Trillium [NASDAQ: TRIL] to be Acquired by Pfizer Inc

Must read

XPeng [NYSE: XPEV] Backed HT Aero Launch Flying Vehicle City Usage Scenarios

XPeng Inc. disclosed that HT Aero has launched future urban usage scenarios for its fifth-generation flying vehicle XPeng X2 (X2). It includes independent...

Metrospaces Choose Cryptobucks as Preferred Cryptocurrency Partner

Metrospaces disclosed that it has selected Cryptobucks as its preferred cryptocurrency partner. It has inked an agreement to consolidate Cryptobucks into all of its...

Novartis [NYSE: NVS] Announces Acquisition of Arctos Medical

Novartis AG disclosed that it has acquired Arctos Medical. This purchase decision will add a pre-clinical optogenetics-based AAV gene therapy program and Arctos’...

Mastercard [NYSE: MA] Announces Launch of Sustainability Innovation Lab

Mastercard Incorporated has introduced a new sustainability innovation lab. The firm disclosed that its new lab will lead the further development of the...

Trillium Therapeutics Inc. [NASDAQ: TRIL] has inked an acquisition agreement with Pfizer Inc. [NYSE: PFE]. As per the acquisition agreement, Trillium will be bought by Pfizer Inc. The planned purchase of Trillium is to be executed by way of a legal plan of arrangement under the Business Corporations Act (British Columbia).

Pfizer believed that the acquisition of Trillium will bolster its dedication to chase scientific discoveries with the addition of potentially best-in-class molecules to its groundbreaking pipeline. The suggested purchase of Trillium develops on its strong track record of leadership in Oncology. It will improve its hematology portfolio as the firm is struggling to enhance results for people living with blood cancers around the world.

Shares of Trillium Therapeutics Inc. [NASDAQ: TRIL] skyrocketed 192.61% at the time of writing on Monday’s premarket trading session. Furthermore, previously in September 2020, as part of the Pfizer Breakthrough Growth Initiative (PBGI), Pfizer spent $25 million in Trillium. Additionally, Pfizer has dedicated itself to providing up to $500 million in total funding to the PBGI.

Financial Details

As per the terms of the agreement, Pfizer will buy all outstanding shares of Trillium not already possessed by Pfizer. Furthermore, the firm will buy shares for an implied equity value of $2.26 billion, or $18.50 per share, in cash. This is equivalent to a 118% premium to the 60-day weighted average price for Trillium.

Additionally, the execution of the deal is dependent on customary closing conditions. The terms include the authorization of 66⅔% of the votes cast by Trillium shareholders. Furthermore, it also includes authorization of 66⅔% of the votes cast by Trillium shareholders.

More articles

Latest article

ReneSola [NYSE: SOL] and Eiffel’s Joint Venture Buys Its First 200 MW Project Portfolio

ReneSola Ltd disclosed that European Solar Energy Development JV has finalized the purchase of its first batch of solar projects with a combined...

Square [NYSE: SQ] Launch its Early Access Program in Spain

Square, Inc. which has earned a reputation as a software, payments, and hardware solution firm for all types of businesses disclosed that it...

Ideanomics [NASDAQ: IDEX] Decides to Increase Stake in Energica

Ideanomics, Inc. disclosed that it has decided to ink an agreement with Energica Company. As per the agreement, the firm has decided to...

L3Harris’ [NYSE: LHX] Robot Chosen to Protect US Air Force Bases Around the Globe

L3Harris Technologies, Inc. disclosed that it has received a huge contract from US Air Force. The firm revealed that its robot will now...

Tower Semiconductor [NASDAQ: TSEM] Introduces Breakthrough LiDAR Technology

Tower Semiconductor Ltd. has introduced a breakthrough development of LiDAR IC technology created for sophisticated driver-assistance systems (ADAS) and ultimately self-driving cars. The...

KKR [NYSE: KKR] Decides to Divest Riata Corporate Park

KKR & Co. Inc. has disclosed that it has decided to divest the Riata Corporate Park. Riata Corporate Park is an eight-building, 688,100...

3D Systems [NYSE: DDD] Unveil VisiJet Wax Jewel Red

3D Systems Corporation has launched the VisiJet Wax Jewel Red. It will allow jewelry makers to design and create more sophisticated, lasting patterns....

Xerox [NYSE: XRX] Announces Transfer of Stock Exchange Listing to Nasdaq from NYSE

Xerox Holdings Corporation has made an important announcement regarding its listing on Stock Exchange. The firm has revealed that it has decided to...